frailty, cardiac and pulmonary disease, mental decline, increased risk for falls, fractures and hospitalization. Even though recognizing sarcopenia can be done through a special questionnaire filling in and clinical test performance, imaging plays a determinant role in sarcopenia's diagnosis confirmation by estimating the muscle quality and quantity. There are various imaging methods that can be used for this purpose, such us ultrasonography, dual energy-ray absorptiometry, computed tomography and Magnetic Resonance Imaging (MRI) 5 .The aim of this review is to present the applications of MRI in sarcopenia assessment, by giving prominence to the advantages of this imaging modality, the specific MRIderived surrogate parameters/biomarkers of sarcopenia and the MRI techniques serving that scope.